| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.48 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |